Literature DB >> 9824850

beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells.

R L von Holtz1, C S Fink, A B Awad.   

Abstract

Epidemiological evidence has shown that men consuming a low-fat, high-fiber diet containing high amounts of plant products have a lower risk of prostate cancer than men consuming a Western diet. One of the main differences between these two diets is the type of dietary fat, including dietary sterols. This study was undertaken to compare the effect of two dietary sterols on prostate cancer cells in vitro. beta-Sitosterol (SIT), the most common plant sterol, and cholesterol, an animal sterol, were compared for effect on LNCaP cell growth, differentiation, apoptosis, and sphingomyelin cycle intermediates. Cells were treated for up to seven days with sterols delivered by a cyclodextrin vehicle. Compared with cholesterol, SIT (16 microM) decreased growth by 24% and induced apoptosis fourfold, which was accompanied by cell rounding and a 50% increase in ceramide production. No effect was observed on differentiation as measured by prostate-specific antigen and prostatic acid phosphatase, although total acid phosphatase increased with SIT treatment for up to seven days. The results suggest that the decrease in cell number and increase in apoptosis associated with SIT treatment are mediated by activating the sphingomyelin cycle.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824850     DOI: 10.1080/01635589809514709

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  34 in total

Review 1.  Clinical nutrition: 7. Functional foods--more than just nutrition.

Authors:  Peter J Jones
Journal:  CMAJ       Date:  2002-06-11       Impact factor: 8.262

2.  Modulation of Angiogenesis, Proliferative Response and Apoptosis by β-Sitosterol in Rat Model of Renal Carcinogenesis.

Authors:  Ramalingam Sharmila; Ganapathy Sindhu
Journal:  Indian J Clin Biochem       Date:  2016-05-24

Review 3.  Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia.

Authors:  Youngjoo Kwon
Journal:  Food Sci Biotechnol       Date:  2019-04-17       Impact factor: 2.391

4.  Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene.

Authors:  Godwin O Ifere; Anita Equan; Kereen Gordon; Peri Nagappan; Joseph U Igietseme; Godwin A Ananaba
Journal:  Cancer Epidemiol       Date:  2010-05-12       Impact factor: 2.984

Review 5.  Antitumor Potential of Immunomodulatory Natural Products.

Authors:  Genoveffa Nuzzo; Giuseppina Senese; Carmela Gallo; Federica Albiani; Lucia Romano; Giuliana d'Ippolito; Emiliano Manzo; Angelo Fontana
Journal:  Mar Drugs       Date:  2022-06-08       Impact factor: 6.085

6.  Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo.

Authors:  Nader S Shenouda; Mary S Sakla; Leslie G Newton; Cynthia Besch-Williford; Norman M Greenberg; Ruth S MacDonald; Dennis B Lubahn
Journal:  Endocrine       Date:  2007-02       Impact factor: 3.633

7.  Bioactive Compound Profiling of Olive Fruit: The Contribution of Genotype.

Authors:  Soraya Mousavi; Vitale Stanzione; Roberto Mariotti; Valerio Mastio; Aristotelis Azariadis; Valentina Passeri; Maria Cristina Valeri; Luciana Baldoni; Marina Bufacchi
Journal:  Antioxidants (Basel)       Date:  2022-03-30

8.  Genotoxic and cytotoxic studies of beta-sitosterol and pteropodine in mouse.

Authors:  R Paniagua-Pérez; E Madrigal-Bujaidar; S Reyes-Cadena; D Molina-Jasso; J Pérez Gallaga; A Silva-Miranda; O Velazco; N Hernández; G Chamorro
Journal:  J Biomed Biotechnol       Date:  2005

9.  Fatty acid and phytosterol content of commercial saw palmetto supplements.

Authors:  Kavitha Penugonda; Brian L Lindshield
Journal:  Nutrients       Date:  2013-09-13       Impact factor: 5.717

10.  Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects.

Authors:  Peter J H Jones; Isabelle Demonty; Yen-Ming Chan; Yael Herzog; Dori Pelled
Journal:  Lipids Health Dis       Date:  2007-10-25       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.